Medicare Enrolled
Dr. Jennifer Sceppa, MD
Dermatopathology Physician · Lancaster, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sceppa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sceppa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sceppa
Dr. Jennifer Sceppa is a dermatopathology physician in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sceppa performed 5,987 Medicare services across 3,588 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sceppa received a total of $1,367 from 17 pharmaceutical and/or device companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sceppa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in PA
$1,367 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,987
Medicare services
Top 15% in PA for dermatopathology physician
3,588
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~299 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
2,833 | $25 | $53 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
890 | $5 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
463 | $57 | $125 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
310 | $23 | $56 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
284 | $34 | $92 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
228 | $19 | $34 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
159 | $75 | $154 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
145 | $62 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $89 | $177 |
| Ultraviolet light skin treatment Application of ultraviolet light to the skin for therapeutic purposes. |
111 | $17 | $50 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
81 | $18 | $38 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
51 | $37 | $71 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $35 | $76 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
40 | $7 | $21 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
40 | $303 | $541 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
39 | $93 | $194 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
35 | $119 | $243 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
24 | $91 | $205 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
18 | $200 | $413 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
16 | $113 | $230 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $60 | $155 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
14 | $60 | $140 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
11 | $84 | $167 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,367
Total received (2018-2024)
Avg $195/year across 7 years
Bottom 44% in PA for dermatopathology physician
17
Companies
65
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,028 (75.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$339 (24.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$486
2023
$562
2022
$98
2021
$27
2020
$19
2019
$106
2018
$69
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$103
Novartis Pharmaceuticals Corporation
$96
ABBVIE INC.
$64
Regeneron Healthcare Solutions, Inc.
$50
E.R. Squibb & Sons, L.L.C.
$47
PFIZER INC.
$36
Galderma Laboratories, L.P.
$28
LEO Pharma Inc.
$23
Incyte Corporation
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$274
E.R. Squibb & Sons, L.L.C.
$226
Janssen Biotech, Inc.
$198
Sun Pharmaceutical Industries Inc.
$116
PFIZER INC.
$88
Regeneron Healthcare Solutions, Inc.
$80
AbbVie Inc.
$73
ABBVIE INC.
$64
Incyte Corporation
$47
Galderma Laboratories, L.P.
$43
Lilly USA, LLC
$40
MAYNE PHARMA COMMERCIAL LLC
$26
LEO Pharma Inc.
$23
STRATA Skin Sciences, Inc.
$19
Genentech USA, Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Stemline Therapeutics Inc.
$13
Top 3 companies account for 51.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · CIBINQO · COSENTYX · DUPIXENT · ELZONRIS · EUCRISA · ILUMYA · LIBTAYO · OPZELURA · RINVOQ · Rituxan · SKYRIZI · Sotyktu · TALTZ · TREMFYA · Winlevi · XTRAC
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatopathology physicians within 10 mi
3
Per 100K population
0.5
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sceppa is a mixed practice specialist, with above-average Medicare volume (top 15% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sceppa experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Sceppa performed 2,833 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sceppa receive payments from pharmaceutical companies?
Yes. Dr. Sceppa received a total of $1,367 from 17 companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sceppa's costs compare to other dermatopathology physicians in Lancaster?
Dr. Sceppa's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sceppa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Lancaster
Browse dermatopathology physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in PA
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in PA
Which PA dermatopathology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology